Literature DB >> 12459672

Evidence for the involvement of spinal cord alpha1 adrenoceptors in nitrous oxide-induced antinociceptive effects in Fischer rats.

Ryo Orii1, Yoko Ohashi, Tianzhi Guo, Laura E Nelson, Toshikazu Hashimoto, Mervyn Maze, Masahiko Fujinaga.   

Abstract

BACKGROUND: In a previous study, the authors found that nitrous oxide (N2O) exposure induces c-Fos (an immunohistochemical marker of neuronal activation) in spinal cord gamma-aminobutyric acid-mediated (GABAergic) neurons in Fischer rats. In this study, the authors sought evidence for the involvement of alpha1 adrenoceptors in the antinociceptive effect of N2O and in activation of GABAergic neurons in the spinal cord.
METHODS: Adult male Fischer rats were injected intraperitoneally with alpha1 adrenoceptor antagonist, alpha2 adrenoceptor antagonist, opioid receptor antagonist, or serotonin receptor antagonist and, 15 min later, were exposed to either air (control) or 75% N2O. In some animals, nociception was investigated with the plantar test after 30 min of exposure, while in other animals, gas exposure was continued for 90 min and the spinal cord was examined for c-Fos immunostaining. In a separate experiment, animals were exposed to the above gases alone, after which the spinal cords were examined immunohistochemically for c-Fos and alpha1 adrenoceptor by double-staining methods.
RESULTS: The antinociceptive effect of N2O was attenuated by prazosin (an alpha1 adrenoceptor antagonist), yohimbine (an alpha2 adrenoceptor antagonist), and naloxone (an opioid receptor antagonist) but not by methysergide and tropisetron (serotonin receptor antagonists). N2O exposure induced c-Fos expression in the spinal cord, which was blocked by prazosin and naloxone but not by other drugs. N2O-induced c-Fos expression was colocalized with alpha1 adrenoceptor immunoreactivity in laminae III-IV.
CONCLUSIONS: These findings support the hypothesis that N2O activates GABAergic interneurons through alpha1 adrenoceptors to produce its antinociceptive effect.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12459672     DOI: 10.1097/00000542-200212000-00018

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  8 in total

1.  Involvement of spinal 5-HT1A receptors in isolation rearing-induced hypoalgesia in mice.

Authors:  Naotaka Horiguchi; Yukio Ago; Kazuki Asada; Yuki Kita; Naoki Hiramatsu; Kazuhiro Takuma; Toshio Matsuda
Journal:  Psychopharmacology (Berl)       Date:  2012-12-29       Impact factor: 4.530

Review 2.  Advances in understanding the actions of nitrous oxide.

Authors:  Dimitris E Emmanouil; Raymond M Quock
Journal:  Anesth Prog       Date:  2007

Review 3.  Neurobiology of nitrous oxide-induced antinociceptive effects.

Authors:  Masahiko Fujinaga; Mervyn Maze
Journal:  Mol Neurobiol       Date:  2002-04       Impact factor: 5.590

4.  Dual effects of intrathecal BAM22 on nociceptive responses in acute and persistent pain--potential function of a novel receptor.

Authors:  Yanguo Hong; Peifang Dai; Jianping Jiang; Xueai Zeng
Journal:  Br J Pharmacol       Date:  2004-01-12       Impact factor: 8.739

5.  Nitrous oxide increases serotonin release in the rat spinal cord.

Authors:  Kumiko Mukaida; Tsutomu Shichino; Kazuhiko Fukuda
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

6.  Pioglitazone rapidly reduces neuropathic pain through astrocyte and nongenomic PPARγ mechanisms.

Authors:  Ryan B Griggs; Renee R Donahue; Jenny Morgenweck; Peter M Grace; Amanda Sutton; Linda R Watkins; Bradley K Taylor
Journal:  Pain       Date:  2015-03       Impact factor: 7.926

Review 7.  Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy.

Authors:  Charles F Zorumski; Peter Nagele; Steven Mennerick; Charles R Conway
Journal:  Front Psychiatry       Date:  2015-12-09       Impact factor: 4.157

8.  Pain condition and sex differences in the descending noradrenergic system following lateral hypothalamic stimulation.

Authors:  Younhee Jeong; Monica A Wagner; Robert J Ploutz-Snyder; Janean E Holden
Journal:  IBRO Rep       Date:  2019-12-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.